Retrograde Bleeding Endometriosis: Bleeding Disorders May Increase Endometriosis Risk

Endometriosis develops when tissue similar to the uterine lining grows outside the uterus. The unique trigger is retrograde menstruation — menstrual blood flowing backward through the fallopian tubes into the pelvis.

Certain populations and risk profiles appear more susceptible to endometriosis, suggesting that factors associated with retrograde bleeding — such as blood volume, clotting biology, and pelvic microenvironment — may play a decisive role in disease development. This raises key questions:

• What makes some pelvic environments “fertile ground” for these misplaced cells?
• Could the amount of retrograde bleeding — and the presence of factors that promote cell survival, clot formation, and new vessel growth — be the real drivers?

Hemostatic Balance and Endometriosis Risk

Historically, research has focused on hormones, immune dysfunction, and inflammation. Now, growing evidence points to another key player: hemostasis — the system that controls bleeding and clotting. This system may influence not only how severe symptoms become, but perhaps whether the disease develops at all.

A pelvic environment that is both pro-coagulant (favoring clot formation) and pro-angiogenic (promoting new blood vessel growth) could help retrograde menstrual cells stick, survive, and form a blood supply.

On the other end of the spectrum, a bleeding-prone environment — as in mild bleeding disorders like von Willebrand disease (vWD) — might increase the volume of retrograde bleeding. This exposes the pelvis to more viable endometrial cells. Could this higher “cell load” tip the balance toward disease? Is it more common than we think?

Retrograde Bleeding and Endometriosis

The amount of menstrual blood reaching the pelvic cavity may be as important as the cells themselves. Along with immune escape, angiogenesis, and lesion survival, the iron burden from recurrent bleeding acts as a constant fuel source. When red blood cells break down, they release iron, driving oxidative stress through ferric reactions — much like a slow-burning mine fire beneath the surface each menstrual cycle.

The surface may damage each cycle, and peritoneal reaction continually feeds inflammation and tissue damage, empowering endometriotic lesions to expand and persist. The amount of menstrual blood reaching the pelvic cavity may be as important as the cells themselves. Certain coagulation or bleeding profiles may create the perfect “niche” for implantation. This could connect the dots between menstrual flow, immune escape, angiogenesis, and lesion survival.

Inflammation and Hemostasis: Two Sides of the Same Coin

Inflammation sparks clotting by activating tissue factor (TF) and reducing natural anticoagulants.
Clotting fuels inflammation through thrombin, fibrin, and platelet activation.

In endometriosis, this relationship is amplified:

• Platelets are activated within lesions and pelvic fluid.
• Lesions produce more TF, which promotes clot formation and drives angiogenesis.
• Many women with endometriosis have elevated fibrinogen and slightly shortened aPTT, suggesting mild hypercoagulability.

This tight link between clotting and inflammation may explain why some displaced endometrial cells survive, implant, and develop their own blood supply.

The Coagulation Axis Defects and Endometriosis

A genetic study revealed that:

• Higher genetically predicted vWF was linked to higher endometriosis risk (OR = 1.26, 95% CI 1.09–1.46).
• Higher genetically predicted ADAMTS13 was linked to lower risk (OR = 0.42, 95% CI 0.30–0.58).

vWF helps platelets stick to vessel walls, while ADAMTS13 trims large vWF multimers. A relative excess of vWF activity could promote lesion establishment; more ADAMTS13 may be protective.

Platelets: Unique Drivers of Vessel Growth

Both natural angiogenesis regulators and thrombin-induced angiogenesis can be disrupted when platelet function or coagulation is impaired. Platelets play a unique dual role:

• They initiate clot formation.
• They release pro-angiogenic factors such as VEGF, PDGF, and serotonin that guide new vessel growth.

When platelet activation is altered, these signals become unbalanced. This may lead to unstable, fragile vessels that leak and support chronic inflammation. In retrograde menstruation, this platelet-driven vascular shift could create an environment where ectopic endometrial tissue implants and thrives, building the pathologic, vascularized microenvironments typical of endometriosis.

Endometriosis may start with retrograde bleeding, but cell survival depends on far more than anatomy. The volume of retrograde bleeding, the balance of clotting and bleeding tendencies, and the angiogenic environment all shape the disease’s course. Links between elevated vWF, reduced ADAMTS13, altered platelet activation, and regulators show that clotting biology may be a critical determinant of risk and progression.

Endometriosis remains an enigmatic, systemic disease — a puzzle that cannot be solved by looking at hormones or immune function alone. Every piece, from retrograde flow mechanics to blood clotting dynamics, needs to be examined if we are to see the whole picture.

References:

• The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study
• Endometriosis and mild bleeding disorders
• The link between inflammation and hemostasis in endometriosis: a call for research
• Blood inflammatory and endothelial markers in women with von Willebrand disease
• Severe recurrent endometriomas in a young woman with congenital von Willebrand disease
• Inherited platelet disorders in women